SANTEN IS WORKING TO BRING A NEW ERA OF PREDICTABILITY AND SUSTAINABILITY TO GLAUCOMA SURGERY
Hear it from your peers
Innovative devices that deliver predictable, sustainable outcomes have the potential to change the way we manage glaucoma by allowing for a more proactive approach to surgery.
What is your experience?
Answer a question and see how your response matches up with your peers’
Device innovation could initiate a new era of proactive glaucoma surgery
- A minimally invasive device would help ensure as little trauma to the eye as possible, expediting healing and patient recovery1
- Subconjunctival drainage has been a proven method for decades to achieve target IOP2
- Innovative device design would help maximize outflow while minimizing hypotony3,4
- Biocompatible material that resists degradation could help deliver more-sustainable results3
Santen is dedicated to advancing proactive glaucoma care with surgical-device innovations.
References: 1. Chan JE, Netland PA. EX-PRESS Glaucoma Filtration Device: efficacy, safety, and predictability. Med Devices (Auckl). 2015;8:381-388. 2. Lee RMH, Bouremel Y, Eames I, Brocchini S, Kaw PT. The implications of an ab interno versus ab externo surgical approach on outflow resistance of a subconjunctival drainage device for intraocular pressure control. Transl Vis Sci Technol. 2019;8(3):58. 3. Amoozgar B, Wei X, Lee JH, et al. A novel flexible microfluidic meshwork to reduce fibrosis in glaucoma surgery. PLoS One. 2017;12(3):e0172556.
4. Agrawal P, Bradshaw SE. Systematic literature review of clinical and economic outcomes of micro-invasive glaucoma surgery (MIGS) in primary open-angle glaucoma. Ophthalmol Ther. 2018;7(1):49-73.